Weill Cornell Medicine investigators have identified in a preclinical model a specific brain circuit whose inhibition appears ...

Anxiety at night is a common feeling of fear or worry that makes it hard to fall or stay asleep, but it’s not a special class ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Anti-anxiety medications have side effects and risks ... or doctor to learn coping techniques or determine the best treatment for you. Identifying anxiety as the cause of your chest pain is ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and ...

Weill Cornell Medicine researchers have identified a brain circuit linked to anxiety that may provide a new drug target, ...

The Food and Drug Administration (FDA) has not approved Benadryl, which contains the active ingredient diphenhydramine, to treat anxiety. The medication is also not intended for long-term use.

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Teens and young adults with anxiety, ADHD, or sleep disorders were more likely to have a diagnosis of addiction to sedatives ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...